130 related articles for article (PubMed ID: 17462692)
21. Influence of hepatitis B virus (HBV) genotype on the clinical course of disease in patients coinfected with HBV and hepatitis delta virus.
Kiesslich D; Crispim MA; Santos C; Ferreira Fde L; Fraiji NA; Komninakis SV; Diaz RS
J Infect Dis; 2009 Jun; 199(11):1608-11. PubMed ID: 19388852
[TBL] [Abstract][Full Text] [Related]
22. The pre-S1 and antigenic loop infectivity determinants of the hepatitis B virus envelope proteins are functionally independent.
Le Duff Y; Blanchet M; Sureau C
J Virol; 2009 Dec; 83(23):12443-51. PubMed ID: 19759159
[TBL] [Abstract][Full Text] [Related]
23. Analysis of host range phenotypes of primate hepadnaviruses by in vitro infections of hepatitis D virus pseudotypes.
Barrera A; Guerra B; Lee H; Lanford RE
J Virol; 2004 May; 78(10):5233-43. PubMed ID: 15113905
[TBL] [Abstract][Full Text] [Related]
24. Modification of the hepatitis B virus envelope protein glycosylation pattern interferes with secretion of viral particles, infectivity, and susceptibility to neutralizing antibodies.
Julithe R; Abou-Jaoudé G; Sureau C
J Virol; 2014 Aug; 88(16):9049-59. PubMed ID: 24899172
[TBL] [Abstract][Full Text] [Related]
25. Mapping of the hepatitis B virus pre-S1 domain involved in receptor recognition.
Barrera A; Guerra B; Notvall L; Lanford RE
J Virol; 2005 Aug; 79(15):9786-98. PubMed ID: 16014940
[TBL] [Abstract][Full Text] [Related]
26. Molecular biologic and pathogenetic analysis of hepatitis delta virus.
Lai MM
J Hepatol; 1995; 22(1 Suppl):127-31. PubMed ID: 7602064
[TBL] [Abstract][Full Text] [Related]
27. Activation of the envelope proteins by a metalloproteinase enables attachment and entry of the hepatitis B virus into T-lymphocyte.
Budkowska A; Maillard P; Theret N; Groh F; Possehl C; Topilko A; Crainic R
Virology; 1997 Oct; 237(1):10-22. PubMed ID: 9344903
[TBL] [Abstract][Full Text] [Related]
28. The middle hepatitis B virus envelope protein is not necessary for infectivity of hepatitis delta virus.
Sureau C; Guerra B; Lee H
J Virol; 1994 Jun; 68(6):4063-6. PubMed ID: 8189544
[TBL] [Abstract][Full Text] [Related]
29. Interaction between hepatitis delta virus-encoded proteins and hepatitis B virus envelope protein domains.
Hourioux C; Sureau C; Poisson F; Brand D; Goudeau A; Roingeard P
J Gen Virol; 1998 May; 79 ( Pt 5)():1115-9. PubMed ID: 9603326
[TBL] [Abstract][Full Text] [Related]
30. Chimeric hepatitis B and C viruses envelope proteins can form subviral particles: implications for the design of new vaccine strategies.
Patient R; Hourioux C; Vaudin P; Pagès JC; Roingeard P
N Biotechnol; 2009 Apr; 25(4):226-34. PubMed ID: 19356608
[TBL] [Abstract][Full Text] [Related]
31. The role of the HBV envelope proteins in the HDV replication cycle.
Sureau C
Curr Top Microbiol Immunol; 2006; 307():113-31. PubMed ID: 16903223
[TBL] [Abstract][Full Text] [Related]
32. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
[TBL] [Abstract][Full Text] [Related]
33. Analysis of hepatitis B virus envelope proteins in assembly and infectivity of human hepatitis delta virus.
Sureau C; Lanford R
Prog Clin Biol Res; 1993; 382():45-51. PubMed ID: 8502715
[No Abstract] [Full Text] [Related]
34. Hepatitis B virus infection is dependent on cholesterol in the viral envelope.
Bremer CM; Bung C; Kott N; Hardt M; Glebe D
Cell Microbiol; 2009 Feb; 11(2):249-60. PubMed ID: 19016777
[TBL] [Abstract][Full Text] [Related]
35. Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan.
Khan A; Kurbanov F; Tanaka Y; Elkady A; Sugiyama M; Dustov A; Mizokami M
J Med Virol; 2008 Feb; 80(2):268-76. PubMed ID: 18098133
[TBL] [Abstract][Full Text] [Related]
36. Snake Deltavirus Utilizes Envelope Proteins of Different Viruses To Generate Infectious Particles.
Szirovicza L; Hetzel U; Kipar A; Martinez-Sobrido L; Vapalahti O; Hepojoki J
mBio; 2020 Mar; 11(2):. PubMed ID: 32184255
[TBL] [Abstract][Full Text] [Related]
37. [Application of serum hepatitis B virus large surface protein determination in lamivudine anti-viral therapy for patients with hepatitis B].
Li GY; Sheng JL; Huang HJ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr; 22(2):133-5. PubMed ID: 18574538
[TBL] [Abstract][Full Text] [Related]
38. Interaction between desialylated hepatitis B virus and asialoglycoprotein receptor on hepatocytes may be indispensable for viral binding and entry.
Owada T; Matsubayashi K; Sakata H; Ihara H; Sato S; Ikebuchi K; Kato T; Azuma H; Ikeda H
J Viral Hepat; 2006 Jan; 13(1):11-8. PubMed ID: 16364077
[TBL] [Abstract][Full Text] [Related]
39. Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein.
Petersen J; Dandri M; Mier W; Lütgehetmann M; Volz T; von Weizsäcker F; Haberkorn U; Fischer L; Pollok JM; Erbes B; Seitz S; Urban S
Nat Biotechnol; 2008 Mar; 26(3):335-41. PubMed ID: 18297057
[TBL] [Abstract][Full Text] [Related]
40. Production of infectious hepatitis delta virus in vitro and neutralization with antibodies directed against hepatitis B virus pre-S antigens.
Sureau C; Moriarty AM; Thornton GB; Lanford RE
J Virol; 1992 Feb; 66(2):1241-5. PubMed ID: 1309901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
